MFN2 and amyotrophic lateral sclerosis: However, to the best of our knowledge, this is the first study to provide a clinical, neurophysiological and molecular characterization of multiple patients affected by amyotrophic lateral sclerosis harbouring MFN2 variants and the largest work to assess their prevalence.